Gold nanostars for efficient in vitro and in vivo real-time SERS detection and drug delivery via plasmonic-tunable Raman/FTIR imaging

Biomaterials

Volumn 106, Issue , 2016, Pages 87-97

  Tian, Furong ^a   Conde, João ^b,c   Bao, Chenchen ^d,e   Chen, Yunsheng ^d   Curtin, James ^a   Cui, Daxiang ^d  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e United Well Technology Limited   (China)

Author keywords

Drug delivery; Gold nanostars; In vivo SERS; Raman FTIR imaging; Theranostics

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL ORGANS; CARDIOLOGY; CELLS; CHEMOTHERAPY; CYTOLOGY; DISEASE CONTROL; DISEASES; DRUG DELIVERY; DRUG DOSAGE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GOLD; MAMMALS; PLASMONICS; PLASMONS; TARGETED DRUG DELIVERY;

ANTI-INFLAMMATORIES; CANCER CHEMOTHERAPY; CARDIO-VASCULAR DISEASE; CELLULAR IMAGING; CHRONIC HEART FAILURES; GOLD NANOSTARS; THERANOSTICS; VIVO BIODISTRIBUTION;

CONTROLLED DRUG DELIVERY;

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; DRUG CARRIER; GOLD NANOSTAR; MACROGOL; MITOXANTRONE; NANOSPHERE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; GOLD; METAL NANOPARTICLE; NANOCAPSULE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; HEART; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTESTINE; KIDNEY; LIVER; LUNG; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SPLEEN; SQUAMOUS CELL LUNG CARCINOMA; ZETA POTENTIAL; ANIMAL; CHEMISTRY; COMPUTER SYSTEM; DRUG MONITORING; MOLECULAR IMAGING; NEOPLASM; PATHOLOGY; PROCEDURES; SURFACE PLASMON RESONANCE; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMPUTER SYSTEMS; CONTRAST MEDIA; DRUG MONITORING; GOLD; METAL NANOPARTICLES; MICE; MOLECULAR IMAGING; NANOCAPSULES; NEOPLASMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SPECTRUM ANALYSIS, RAMAN; SURFACE PLASMON RESONANCE; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME;

EID: 84982305841     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.08.014     Document Type: Article

References (42)

1. [1] Tong, S., Fine, E.J., Lin, Y., Cradick, T.J., Bao, G., Nanomedicine: tiny particles and machines give huge gains. Ann. Biomed. Eng. 42:2 (2014), 243–259.
2. [2] Liang, X.J., Chen, C., Zhao, Y., Wang, P.C., Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol. Biol. 596 (2010), 467–488.
3. [3] Patel, K.J., Tredan, O., Tannock, I.F., Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues. Cancer Chemother. Pharmacol. 72:1 (2013), 127–138.
4. [4] Giljohann, D.A., Seferos, D.S., Daniel, W.L., Massich, M.D., Patel, P.C., Mirkin, C.A., Gold nanoparticles for biology and medicine. Angew. Chem. Int. Ed. Engl. 49:19 (2010), 3280–3294.
5. [5] Bao, C.C., Conde, J., Polo, E., del Pino, P., Moros, M., Baptista, P.V., Grazu, V., Cui, D.X., de la Fuente, J.M., A promising road with challenges: where are gold nanoparticles in translational research?. Nanomedicine 9:15 (2014), 2353–2370.
6. [6] Conde, J., Dias, J.T., Grazu, V., Moros, M., Baptista, P.V., de la Fuente, J.M., Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front. Chem., 2, 2014, 48.
7. [7] Murphy, C.J., Gole, A.M., Stone, J.W., Sisco, P.N., Alkilany, A.M., Goldsmith, E.C., Baxter, S.C., Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 41:12 (2008), 1721–1730.
8. [8] Conde, J., Tian, F., Hernandez, Y., Bao, C., Cui, D., Janssen, K.P., Ibarra, M.R., Baptista, P.V., Stoeger, T., de la Fuente, J.M., In vivo tumor targeting via nanoparticle-mediated therapeutic sirna coupled to inflammatory response in lung cancer mouse models. Biomaterials 34:31 (2013), 7744–7753.
9. [9] Conde, J., Oliva, N., Artzi, N., Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance. Proc. Natl. Acad. Sci. U. S. A. 112:11 (2015), E1278–E1287.
10. [10] Harmsen, S., Huang, R., Wall, M.A., Karabeber, H., Samii, J.M., Spaliviero, M., White, J.R., Monette, S., O'Connor, R., Pitter, K.L., Sastra, S.A., Saborowski, M., Holland, E.C., Singer, S., Olive, K.P., Lowe, S.W., Blasberg, R.G., Kircher, M.F., Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging. Sci. Transl. Med. 7:271 (2015), 271–277.
11. [11] Conde, J., Ambrosone, A., Sanz, V., Hernandez, Y., Marchesano, V., Tian, F.R., Child, H., Berry, C.C., Ibarra, M.R., Baptista, P.V., Tortiglione, C., de la Fuente, J.M., Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. Acs Nano 6:9 (2012), 8316–8324.
12. [12] Conde, J., Oliva, N., Zhang, Y., Artzi, N., Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. Nat. Mater., 2016 (in press).
13. [13] Tian, F., Bonnier, F., Casey, A., Shanahan, A.E., Byrne, H.J., Surface enhanced Raman scattering with gold nanoparticles: effect of particle shape. Anal. Methods 6:22 (2014), 9116–9123.
14. [14] Panchapakesan, B., Book-Newell, B., Sethu, P., Rao, M., Irudayaraj, J., Gold nanoprobes for theranostics. Nanomedicine (Lond.) 6:10 (2011), 1787–1811.
15. [15] Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., Niidome, Y., PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release Off. J. Control. Release Soc. 114:3 (2006), 343–347.
16. [16] Hirsch, L.R., Stafford, R.J., Bankson, J.A., Sershen, S.R., Rivera, B., Price, R.E., Hazle, J.D., Halas, N.J., West, J.L., Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. U. S. A. 100:23 (2003), 13549–13554.
17. [17] Rodriguez-Oliveros, R., Sanchez-Gil, J.A., Gold nanostars as thermoplasmonic nanoparticles for optical heating. Opt. Express 20:1 (2012), 621–626.
18. [18] Rodriguez-Lorenzo, L., Krpetic, Z., Barbosa, S., Alvarez-Puebla, R.A., Liz-Marzan, L.M., Prior, I.A., Brust, M., Intracellular mapping with sers-encoded gold nanostars. Integr. Biol. Quant. Biosci. Nano Macro 3:9 (2011), 922–926.
19. [19] Li, M., Kang, J.W., Dasari, R.R., Barman, I., Shedding light on the extinction-enhancement duality in gold nanostar-enhanced Raman spectroscopy. Angew. Chem. Int. Ed. Engl. 53:51 (2014), 14115–14119.
20. [20] Dam, D.H., Culver, K.S., Kandela, I., Lee, R.C., Chandra, K., Lee, H., Mantis, C., Ugolkov, A., Mazar, A.P., Odom, T.W., Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars. Nanomedicine 11:3 (2015), 671–679.
21. [21] Vo-Dinh, T., Fales, A.M., Griffin, G.D., Khoury, C.G., Liu, Y., Ngo, H., Norton, S.J., Register, J.K., Wang, H.N., Yuan, H., Plasmonic nanoprobes: from chemical sensing to medical diagnostics and therapy. Nanoscale 5:21 (2013), 10127–10140.
22. [22] Liu, Y., Yuan, H., Kersey, F.R., Register, J.K., Parrott, M.C., Vo-Dinh, T., Plasmonic gold nanostars for multi-modality sensing and diagnostics. Sens. (Basel) 15:2 (2015), 3706–3720.
23. [23] Esenturk, E.N., Walker, A.R.H., Surface-enhanced Raman scattering spectroscopy via gold nanostars. J. Raman Spectrosc. 40:1 (2009), 86–91.
24. [24] Bi, S., Jia, X., Ye, J., Dong, Y., Linear light-scattering of gold nanostars for versatile biosensing of nucleic acids and proteins using exonuclease iii as biocatalyst to signal amplification. Biosens. Bioelectron. 71 (2015), 427–433.
25. [25] Liu, Y., et al. A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy. Theranostics 5 (2015), 946–960.
26. [26] Yuan, H., Khoury, C.G., Hwang, H., Wilson, C.M., Grant, G.A., Vo-Dinh, T., Gold nanostars: surfactant-free synthesis, 3d modelling, and two-photon photoluminescence imaging. Nanotechnology, 23(7), 2012, 075102.
27. [27] Khlebtsov, N., Dykman, L., Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40:3 (2011), 1647–1671.
28. [28] De Jong, W.H., Borm, P.J., Drug delivery and nanoparticles:applications and hazards. Int. J. Nanomedicine 3:2 (2008), 133–149.
29. [29] Xie, J.P., Lee, J.Y., Wang, D.I.C., Seedless, surfactantless, high-yield synthesis of branched gold nanocrystals in hepes buffer solution. Chem. Mater. 19:11 (2007), 2823–2830.
30. [30] Regev, R., Yeheskely-Hayon, D., Katzir, H., Eytan, G.D., Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanism. Biochem. Pharmacol 70 (2005), 161–169.
31. [31] Homolya, L., Orbán, T.I., Csanády, L., Sarkadi, B., Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane. Biochim. Biophys. Acta 1808:1 (2011), 154–163.
32. [32] Shenkenberg, T.D., Von Hoff, D.D., Mitoxantrone: a new anticancer drug with significant clinical activity. Ann. Intern Med. 105:1 (1986), 67–81.
33. [33] Jin, R., Cao, Y., Mirkin, C.A., Kelly, K.L., Schatz, G.C., Zheng, J.G., Photoinduced conversion of silver nanospheres to nanoprisms. Science 294:5548 (2001), 1901–1903.
34. [34] Millstone, J.E., Hurst, S.J., Metraux, G.S., Cutler, J.I., Mirkin, C.A., Colloidal gold and silver triangular nanoprisms. Small 5:6 (2009), 646–664.
35. [35] Mikoliunaite, L., Rodriguez, R.D., Sheremet, E., Kolchuzhin, V., Mehner, J., Ramanavicius, A., Zahn, D.R., The substrate matters in the Raman spectroscopy analysis of cells. Sci. Rep., 5, 2015, 13150.
36. [36] Ganbold, E.O., Yoon, J., Kim, D., Joo, S.W., Nonidentical intracellular drug release rates in Raman and fluorescence spectroscopic determination. Phys. Chem. Chem. Phys. PCCP 17:5 (2015), 3019–3023.
37. [37] Chen, H., Zhang, X., Dai, S., Ma, Y., Cui, S., Achilefu, S., Gu, Y., Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. Theranostics 3:9 (2013), 633–649.
38. [38] Ostrowska, K.M., et al. Correlation of p16INK4A expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells. Analyst 136 (2011), 1365–1373.
39. [39] Kreyling, W.G., Semmler-Behnke, M., Seitz, J., Scymczak, W., Wenk, A., Mayer, P., Takenaka, S., Oberdorster, G., Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol. 21:Suppl 1 (2009), 55–60.
40. [40] Nedosekin, D.A., Shashkov, E.V., Galanzha, E.I., Hennings, L., Zharov, V.P., Photothermal multispectral image cytometry for quantitative histology of nanoparticles and micrometastasis in intact, stained and selectively burned tissues. Cytom. Part A J. Int. Soc. Anal. Cytol. 77:11 (2010), 1049–1058.
41. [41] Gong, K., Zhang, Z., Sun, X., Zhang, X., Li, A., Yan, J., Luo, Q., Gao, Y., Feng, Y., The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure. Am. Heart J. 151:1 (2006), 62–68.
42. [42] Bao, C., Conde, J., Curtin, J., Artzi, N., Tian, F., Cui, D., Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis. Sci. Rep., 5, 2015, 12297.